Advanced engineering and medical technology supplier Avingtrans (LON: AVG) is in a strong position to develop over the next few years. The cost of developing the medical imaging technology is holding back short-term profit, but there is huge longer-term potential.
Avingtrans is heavily investing in developing compact 3D x-ray systems and the initial reaction to the technology is positive. The veterinary market is the first to be commercially exploited ahead of FDA approval for humans. There are also sales for non-destructive evaluation of products.
Management expects 510(k) FDA approval...
